PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026

PAVmed (Nasdaq: PAVM) announced it will host a second quarter 2026 business update conference call and webcast on Friday, August 14, 2026, at 8:30 AM ET.

Rhea-AI Summary

PAVmed (Nasdaq: PAVM) announced it will host a second quarter 2026 business update conference call and webcast on Friday, August 14, 2026, at 8:30 AM ET. CEO Lishan Aklog will discuss business operations and growth strategy, and President/CFO Dennis McGrath will review second quarter 2026 financial results.

Argus Jul 31 session 3 alerts

-3.28% close to close 0.4x rel. volume Open Argus

Details

News Market Reaction – LUCD

$165.02M Mkt Cap at Peak Alert

On Jul 31, the day this news came out, LUCD closed 3.28% below the previous close. Our momentum scanner recorded 3 alerts for this stock that day.

Data tracked by StockTitan Argus for the Jul 31 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Conference Call and Webcast at 8:30 AM ET

NEW YORK, July 31, 2026 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Friday, August 14, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath, PAVmed's President and Chief Financial Officer, will discuss the Company's second quarter 2026 financial results.

The webcast will be available at the investor relations section of the Company's website at pavmed.com.  Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "PAVmed Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com.

About PAVmed
PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard^® Esophageal DNA Test and EsoCheck^® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer to mitigate the risks of esophageal cancer deaths. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform.

For more information about PAVmed, please visit pavmed.com.

For more information about Lucid Diagnostics, please visit luciddx.com.

For more information about Veris Health, please visit verishealth.com. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pavmed-to-hold-second-quarter-2026-business-update-conference-call-and-webcast-on-august-14-2026-302838867.html

SOURCE PAVmed Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is PAVmed's Q2 2026 business update conference call and webcast?

PAVmed’s Q2 2026 business update call and webcast is scheduled for Friday, August 14, 2026, at 8:30 AM ET. According to PAVmed, the event will cover a business update, operations, growth strategy, and second quarter 2026 financial results.

How can investors access the PAVmed (PAVM) Q2 2026 earnings conference call by phone?

Investors can access the PAVmed Q2 2026 call by dialing 1-800-836-8184 in the U.S. or 1-646-357-8785 internationally. According to PAVmed, callers should provide the conference name “PAVmed Business Update” to the operator to join the call.

Where can I watch the PAVmed (PAVM) Q2 2026 webcast online?

The PAVmed Q2 2026 webcast will be available through the investor relations section of pavmed.com. According to PAVmed, investors can access the live webcast and, after the event, a replay hosted on the same investor relations webpage.

Will there be a replay of PAVmed's August 14, 2026 business update webcast?

Yes, a replay of PAVmed’s August 14, 2026 business update call will be available for 30 days. According to PAVmed, investors can access this replay via the investor relations section of the company’s website at pavmed.com after the call concludes.

What topics will be covered on the PAVmed Q2 2026 business update call?

The call will feature a business update, operations overview, and growth strategy, plus Q2 2026 financial results. According to PAVmed, CEO Lishan Aklog will address business matters, while President/CFO Dennis McGrath will discuss second quarter 2026 financial performance.

Who will present on PAVmed's second quarter 2026 business update conference call?

According to PAVmed, Lishan Aklog, M.D., Chairman and CEO, will provide a business update, and Dennis McGrath, President and CFO, will review Q2 2026 financial results. Both executives will speak on the August 14, 2026 call and webcast.